CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer

被引：6
|
作者：
Rosenberg, Steven A. [1 ]
机构：
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 24期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; ADOPTIVE IMMUNOTHERAPY; ANTIGENS; REGRESSION; THERAPY;
D O I：
10.1158/1078-0432.CCR-14-3131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The article by Rosenberg and colleagues, which was published in the July 1, 2011, issue of Clinical Cancer Research, demonstrated the power of the adoptive transfer of autologous antitumor T cells to mediate the complete, durable, and likely curative regression of cancer in patients with heavily pretreated metastatic melanoma. It also provided a stimulus to the development of cell transfer approaches for other cancer types using both natural and genetically engineered lymphocytes. (C)2015 AACR.
引用
收藏
页码：5409 / 5411
页数：3
相关论文
共 32 条
  • [1] CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer
    Mehra, Niven
    Zafeiriou, Zafeiris
    Lorente, David
    Terstappen, Leon W. M. M.
    de Bono, Johann S.
    CLINICAL CANCER RESEARCH, 2015, 21 (22) : 4992 - 4995
  • [2] CCR 20th Anniversary Commentary: Paving the Way for Circulating Tumor Cells
    Allard, W. Jeffrey
    Terstappen, Leon W. M. M.
    CLINICAL CANCER RESEARCH, 2015, 21 (13) : 2883 - 2885
  • [3] CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer
    Rahman, Mohammad Aminur
    Shin, Dong M.
    CLINICAL CANCER RESEARCH, 2015, 21 (20) : 4499 - 4501
  • [4] CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping
    Nielsen, Torsten O.
    Perou, Charles M.
    CLINICAL CANCER RESEARCH, 2015, 21 (08) : 1779 - 1781
  • [5] CCR 20th Anniversary Commentary: In the Beginning, There Was PS-341
    Teicher, Beverly A.
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 939 - 941
  • [6] CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic Portfolio
    Bates, Susan E.
    Robey, Robert W.
    Piekarz, Richard L.
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2195 - 2197
  • [7] CCR 20th Anniversary Commentary: Stayin' Alive-Antiapoptotic Proteins and Breast Cancer
    Yee, Douglas
    CLINICAL CANCER RESEARCH, 2015, 21 (04) : 665 - 666
  • [8] CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials
    Carey, Lisa A.
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4027 - 4029
  • [9] CCR 20th Anniversary Commentary: Vorinostat-Gateway to Epigenetic Therapy
    Kelly, Wm Kevin
    Marks, Paul
    Richon, Victoria M.
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2198 - 2200
  • [10] CCR 20th Anniversary Commentary: Chimeric Antigen Receptors-From Model T to the Tesla
    Hwu, Patrick
    CLINICAL CANCER RESEARCH, 2015, 21 (14) : 3099 - 3101
1234